During the past decade, Hebei North University conducted 0 clinical trials. In the 10-year time frame, 0 clinical trials started and 0 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

According to Clinical.Site data, the most researched conditions in "Hebei North University" are "Stroke" (2 trials) and "Transient Ischemic Attack" (1 trials). Many other conditions were trialed in "Hebei North University" in a lesser frequency.

Most popular intervention types in "Hebei North University" are "Drug" (2 trials). Other intervention types were less common.

The name of intervention was led by "Aspirin" (1 trials), "Aspirin / Clopidogrel, Atorvastatin / Simvastatin" (1 trials), "Asprin / Clopidogrel, Atorvastatin / Simvastatin" (1 trials) and "Butylphthalide Soft Capsules" (1 trials). Other intervention names were less common.

The vast majority of trials in "Hebei North University" are 2 trials for "All" genders.

Currently, there are NaN active trials in "Hebei North University". undefined are not yet recruiting, undefined are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 1 completed trials in Hebei North University, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Hebei North University, 0 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 0 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 1 trials, and there were also 1 trials that are defined as “Not Applicable".